KR102375480B1 - 인 보호기 및 이의 제조 방법 및 용도 - Google Patents

인 보호기 및 이의 제조 방법 및 용도 Download PDF

Info

Publication number
KR102375480B1
KR102375480B1 KR1020167033381A KR20167033381A KR102375480B1 KR 102375480 B1 KR102375480 B1 KR 102375480B1 KR 1020167033381 A KR1020167033381 A KR 1020167033381A KR 20167033381 A KR20167033381 A KR 20167033381A KR 102375480 B1 KR102375480 B1 KR 102375480B1
Authority
KR
South Korea
Prior art keywords
hydrogen
alkyl
halogen
group
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167033381A
Other languages
English (en)
Korean (ko)
Other versions
KR20160147973A (ko
Inventor
더글라스 제이 델링거
루카 몬프레골라
마빈 카루터스
미텀 로이
Original Assignee
애질런트 테크놀로지스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 애질런트 테크놀로지스, 인크. filed Critical 애질런트 테크놀로지스, 인크.
Publication of KR20160147973A publication Critical patent/KR20160147973A/ko
Application granted granted Critical
Publication of KR102375480B1 publication Critical patent/KR102375480B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
KR1020167033381A 2014-04-30 2015-04-30 인 보호기 및 이의 제조 방법 및 용도 Active KR102375480B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461986594P 2014-04-30 2014-04-30
US61/986,594 2014-04-30
PCT/US2015/028624 WO2015168461A2 (en) 2014-04-30 2015-04-30 Phosphorous protecting groups and methods of preparation and use thereof

Publications (2)

Publication Number Publication Date
KR20160147973A KR20160147973A (ko) 2016-12-23
KR102375480B1 true KR102375480B1 (ko) 2022-03-16

Family

ID=54354752

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167033381A Active KR102375480B1 (ko) 2014-04-30 2015-04-30 인 보호기 및 이의 제조 방법 및 용도

Country Status (6)

Country Link
US (3) US10196418B2 (https=)
EP (2) EP3137478B1 (https=)
JP (1) JP6730932B2 (https=)
KR (1) KR102375480B1 (https=)
CN (1) CN106255697B (https=)
WO (1) WO2015168461A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102375480B1 (ko) 2014-04-30 2022-03-16 애질런트 테크놀로지스, 인크. 인 보호기 및 이의 제조 방법 및 용도
CA3015823A1 (en) * 2016-03-13 2017-09-21 Wave Life Sciences Ltd. Compositions and methods for phosphoramidite and oligonucleotide synthesis
MA46905A (fr) 2016-11-23 2019-10-02 Wave Life Sciences Ltd Compositions et procédés de synthèse de phosphoramidites et d'oligonucléotides
US10406148B2 (en) 2017-05-01 2019-09-10 Theravance Biopharma R&D Ip, Llc Methods of treatment using a JAK inhibitor compound
CN113508103A (zh) 2019-02-28 2021-10-15 富士胶片株式会社 肽化合物的制造方法、保护基形成用试药及稠合多环芳香族烃化合物
JP7628073B2 (ja) 2019-02-28 2025-02-07 富士フイルム株式会社 ペプチド化合物の製造方法、保護基形成用試薬、及び、芳香族複素環化合物
JP7814933B2 (ja) * 2019-08-29 2026-02-17 富士フイルム株式会社 核酸化合物の製造方法、及び、核酸化合物
EP3805242A1 (en) * 2019-10-07 2021-04-14 Sterna Biologicals GmbH & Co. KG Method for the production of a catalytically active dna molecule having improved activity and its use in a method of treating asthma
TW202317550A (zh) 2021-06-25 2023-05-01 美商施萬生物製藥研發 Ip有限責任公司 作為jak抑制劑之咪唑吲唑化合物
CN113461743B (zh) * 2021-07-09 2023-03-17 中国石油大学(华东) 6-甲硫基乙基嘌呤-2’-脱氧核苷及其制备方法和应用
KR20240100491A (ko) 2021-10-15 2024-07-01 코덱시스, 인코포레이티드 조작된 말단 데옥시뉴클레오티딜 트랜스퍼라제 변이체

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000507928A (ja) * 1996-06-10 2000-06-27 サントル・ナショナル・ドゥ・ラ・ルシェルシュ・シャンティフィック（セ・エヌ・エール・エス） ホスホトリエステルオリゴヌクレオチド、アミダイト、およびそれらの調製法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
JPS6251695A (ja) * 1985-08-29 1987-03-06 Yuki Gosei Yakuhin Kogyo Kk ホスホロアミダイト類の合成法
NL8700724A (nl) * 1987-03-27 1988-10-17 Univ Eindhoven Tech Poly(deoxyribonucleotiden), farmaceutische samenstellingen, gebruik en bereiding van de poly(deoxyribonucleotiden).
US5948902A (en) 1997-11-20 1999-09-07 South Alabama Medical Science Foundation Antisense oligonucleotides to human serine/threonine protein phosphatase genes
US6020475A (en) * 1998-02-10 2000-02-01 Isis Pharmeuticals, Inc. Process for the synthesis of oligomeric compounds
US6531590B1 (en) * 1998-04-24 2003-03-11 Isis Pharmaceuticals, Inc. Processes for the synthesis of oligonucleotide compounds
US6274725B1 (en) * 1998-06-02 2001-08-14 Isis Pharmaceuticals, Inc. Activators for oligonucleotide synthesis
US6222030B1 (en) 1998-08-03 2001-04-24 Agilent Technologies, Inc. Solid phase synthesis of oligonucleotides using carbonate protecting groups and alpha-effect nucleophile deprotection
US7135565B2 (en) 2000-07-28 2006-11-14 Agilent Technologies, Inc. Synthesis of polynucleotides using combined oxidation/deprotection chemistry
US20060178507A1 (en) * 2004-12-30 2006-08-10 Berry & Associates, Inc. Fluorous oligonucleotide reagents and affinity purification of oligonucleotides
KR20130022437A (ko) * 2011-08-22 2013-03-07 삼성전자주식회사 광분해성 화합물을 사용한, 비특이적 증폭의 감소를 위한 신규한 ｐｃｒ 방법
US9950001B2 (en) * 2012-08-20 2018-04-24 The Regents Of The University Of California Polynucleotides having bioreversible groups
KR102375480B1 (ko) 2014-04-30 2022-03-16 애질런트 테크놀로지스, 인크. 인 보호기 및 이의 제조 방법 및 용도

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000507928A (ja) * 1996-06-10 2000-06-27 サントル・ナショナル・ドゥ・ラ・ルシェルシュ・シャンティフィック（セ・エヌ・エール・エス） ホスホトリエステルオリゴヌクレオチド、アミダイト、およびそれらの調製法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
F.Seela et al., Tetrahedron, 1999, Vol.55, pp.9481-9500*
H.Li et al., Bioorganic & Medicinal Chem. Letters, 2004, Vol.14, pp.6031-6034*
L.J.McBride et al., J. Am. Chem. Soc., 1986, Vol.108, pp.2040-2048*

Also Published As

Publication number Publication date
US20150315227A1 (en) 2015-11-05
US11104699B2 (en) 2021-08-31
US20190194242A1 (en) 2019-06-27
US11584773B2 (en) 2023-02-21
KR20160147973A (ko) 2016-12-23
EP3137478B1 (en) 2021-09-22
EP3943500A1 (en) 2022-01-26
WO2015168461A2 (en) 2015-11-05
US20220002334A1 (en) 2022-01-06
CN106255697A (zh) 2016-12-21
JP6730932B2 (ja) 2020-07-29
WO2015168461A3 (en) 2015-12-23
CN106255697B (zh) 2020-04-28
US10196418B2 (en) 2019-02-05
JP2017518966A (ja) 2017-07-13
EP3137478A2 (en) 2017-03-08
EP3137478A4 (en) 2018-03-07

Similar Documents

Publication Publication Date Title
KR102375480B1 (ko) 인 보호기 및 이의 제조 방법 및 용도
EP2277886B1 (en) The use of n-alkyl imidazole for sulfurization of oligonucleotides with an acetyl disulfide
EP1954707B1 (en) Polynucleotide containing a phosphate mimetic
CN102639552B (zh) 含有O-缩醛乙酰丙酸酯基团(O-acetal levulinyl ester)的RNA单体及其在RNA微阵列中的应用
KR102190852B1 (ko) 변형된 커플링 프로토콜을 이용하는 올리고머 화합물의 제조 방법
EP3154996B1 (en) Protecting groups for "z nucleotide" and methods thereof
WO2015061246A1 (en) Method for solution phase detritylation of oligomeric compounds
WO1999064434A1 (en) Synthetic methods and intermediates for triester oligonucleotides
WO1995031470A2 (en) Antisense inhibitors of gene expression
CN116981676A (zh) 用于减少由最终脱保护期间烷基胺暴露造成的脱嘧啶化的氢化肉桂酰基保护的核糖鸟苷亚磷酰胺
JP2025510019A (ja) 方法および化合物
WO2004048376A1 (ja) 二環性ナフチリジンヌクレオシド
CA2078256A1 (en) Synthesis of sulfide-linked di-or oligonucleotide analogs and incorporation into antisense dna or rna
Matthew Piperakis Synthesis and properties of nucleic acid duplexes and quadruplexes containing 3'-S-phosphorothiolate linkages
HK1126224B (en) Polynucleotide containing a phosphate mimetic

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20161129

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200320

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210728

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20220120

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220314

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220314

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20250217

Start annual number: 4

End annual number: 4